Literature DB >> 28791420

Melatonin as a mitochondrial protector in neurodegenerative diseases.

Pawaris Wongprayoon1, Piyarat Govitrapong2,3.   

Abstract

Mitochondria are crucial organelles as their role in cellular energy production of eukaryotes. Because the brain cells demand high energy for maintaining their normal activities, disturbances in mitochondrial physiology may lead to neuropathological events underlying neurodegenerative conditions such as Alzheimer's disease, Parkinson's disease and Huntington's disease. Melatonin is an endogenous compound with a variety of physiological roles. In addition, it possesses potent antioxidant properties which effectively play protective roles in several pathological conditions. Several lines of evidence also reveal roles of melatonin in mitochondrial protection, which could prevent development and progression of neurodegeneration. Since the mitochondrial dysfunction is a primary event in neurodegeneration, the neuroprotection afforded by melatonin is thereby more effective in early stages of the diseases. This article reviews mechanisms which melatonin exerts its protective roles on mitochondria as a potential therapeutic strategy against neurodegenerative disorders.

Entities:  

Keywords:  Alzheimer’s disease; Huntington’s disease; Melatonin; Mitochondria; Neurodegeneration; Parkinson’s disease

Mesh:

Substances:

Year:  2017        PMID: 28791420     DOI: 10.1007/s00018-017-2614-x

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  85 in total

Review 1.  Alzheimer's disease pathogenesis and therapeutic interventions.

Authors:  M S Parihar; Taruna Hemnani
Journal:  J Clin Neurosci       Date:  2004-06       Impact factor: 1.961

2.  Matrilineal inheritance of complex I dysfunction in a multigenerational Parkinson's disease family.

Authors:  R H Swerdlow; J K Parks; J N Davis; D S Cassarino; P A Trimmer; L J Currie; J Dougherty; W S Bridges; J P Bennett; G F Wooten; W D Parker
Journal:  Ann Neurol       Date:  1998-12       Impact factor: 10.422

3.  Mechanism of neuroprotection of melatonin against beta-amyloid neurotoxicity.

Authors:  M Ionov; V Burchell; B Klajnert; M Bryszewska; A Y Abramov
Journal:  Neuroscience       Date:  2011-02-24       Impact factor: 3.590

4.  Maternal inheritance in Parkinson's disease.

Authors:  G F Wooten; L J Currie; J P Bennett; M B Harrison; J M Trugman; W D Parker
Journal:  Ann Neurol       Date:  1997-02       Impact factor: 10.422

5.  Melatonin reduces the neuronal loss, downregulation of dopamine transporter, and upregulation of D2 receptor in rotenone-induced parkinsonian rats.

Authors:  Chun-Hung Lin; Jui-Yen Huang; Cheng-Hsin Ching; Jih-Ing Chuang
Journal:  J Pineal Res       Date:  2008-03       Impact factor: 13.007

6.  Protective effect of melatonin in a chronic experimental model of Parkinson's disease.

Authors:  Isaac Antolín; Juan Carlos Mayo; Rosa María Sainz; María de los Angeles del Brío; Federico Herrera; Vanesa Martín; Carmen Rodríguez
Journal:  Brain Res       Date:  2002-07-12       Impact factor: 3.252

7.  Nicotinamide riboside restores cognition through an upregulation of proliferator-activated receptor-γ coactivator 1α regulated β-secretase 1 degradation and mitochondrial gene expression in Alzheimer's mouse models.

Authors:  Bing Gong; Yong Pan; Prashant Vempati; Wei Zhao; Lindsay Knable; Lap Ho; Jun Wang; Magdalena Sastre; Kenjiro Ono; Anthony A Sauve; Giulio M Pasinetti
Journal:  Neurobiol Aging       Date:  2013-01-09       Impact factor: 4.673

8.  Amyloid-beta and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice.

Authors:  Virginie Rhein; Xiaomin Song; Andreas Wiesner; Lars M Ittner; Ginette Baysang; Fides Meier; Laurence Ozmen; Horst Bluethmann; Stefan Dröse; Ulrich Brandt; Egemen Savaskan; Christian Czech; Jürgen Götz; Anne Eckert
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-06       Impact factor: 11.205

9.  Differential effects of melatonin on amyloid-beta peptide 25-35-induced mitochondrial dysfunction in hippocampal neurons at different stages of culture.

Authors:  Weiguo Dong; Fang Huang; Wenguo Fan; Shaowu Cheng; Yue Chen; Wenguang Zhang; Hong Shi; Hongwen He
Journal:  J Pineal Res       Date:  2009-12-23       Impact factor: 13.007

10.  Melatonin protects against rotenone-induced oxidative stress in a hemiparkinsonian rat model.

Authors:  Karuppagounder S Saravanan; Kizhakke M Sindhu; Kochupurackal P Mohanakumar
Journal:  J Pineal Res       Date:  2007-04       Impact factor: 13.007

View more
  16 in total

1.  Melatonin Prevents Non-image-Forming Visual System Alterations Induced by Experimental Glaucoma in Rats.

Authors:  María F González Fleitas; Julián Devouassoux; Marcos L Aranda; Hernán H Dieguez; Juan S Calanni; Agustina Iaquinandi; Pablo H Sande; Damián Dorfman; Ruth E Rosenstein
Journal:  Mol Neurobiol       Date:  2021-03-31       Impact factor: 5.590

Review 2.  Mitochondrial dysfunction in perinatal asphyxia: role in pathogenesis and potential therapeutic interventions.

Authors:  Puneet K Samaiya; Sairam Krishnamurthy; Ashok Kumar
Journal:  Mol Cell Biochem       Date:  2021-09-01       Impact factor: 3.396

Review 3.  Mitochondria: Central Organelles for Melatonin's Antioxidant and Anti-Aging Actions.

Authors:  Russel J Reiter; Dun Xian Tan; Sergio Rosales-Corral; Annia Galano; Xin Jia Zhou; Bing Xu
Journal:  Molecules       Date:  2018-02-24       Impact factor: 4.411

Review 4.  Neuroprotection in Glaucoma: Old and New Promising Treatments.

Authors:  Dario Rusciano; Salvatore Pezzino; Maria Giulia Mutolo; Rossella Giannotti; Aloisa Librando; Nicola Pescosolido
Journal:  Adv Pharmacol Sci       Date:  2017-10-17

5.  Melatonin regulates mitochondrial dynamics and alleviates neuron damage in prion diseases.

Authors:  Xixi Zhang; Deming Zhao; Wei Wu; Syed Zahid Ali Shah; Mengyu Lai; Dongming Yang; Jie Li; Zhiling Guan; Wen Li; Hongli Gao; Huafen Zhao; Xiangmei Zhou; Lifeng Yang
Journal:  Aging (Albany NY)       Date:  2020-06-10       Impact factor: 5.682

Review 6.  Dietary Melatonin Supplementation Could Be a Promising Preventing/Therapeutic Approach for a Variety of Liver Diseases.

Authors:  Francesca Bonomini; Elisa Borsani; Gaia Favero; Luigi F Rodella; Rita Rezzani
Journal:  Nutrients       Date:  2018-08-21       Impact factor: 5.717

Review 7.  Aging, Melatonin, and the Pro- and Anti-Inflammatory Networks.

Authors:  Rüdiger Hardeland
Journal:  Int J Mol Sci       Date:  2019-03-11       Impact factor: 5.923

Review 8.  Role of Cardiolipin in Mitochondrial Function and Dynamics in Health and Disease: Molecular and Pharmacological Aspects.

Authors:  Giuseppe Paradies; Valeria Paradies; Francesca M Ruggiero; Giuseppe Petrosillo
Journal:  Cells       Date:  2019-07-16       Impact factor: 6.600

9.  Melatonin Protects Intervertebral Disc from Degeneration by Improving Cell Survival and Function via Activation of the ERK1/2 Signaling Pathway.

Authors:  Jun Ge; Quan Zhou; Junjie Niu; Yingjie Wang; Qi Yan; Cenhao Wu; Jiale Qian; Huilin Yang; Jun Zou
Journal:  Oxid Med Cell Longev       Date:  2019-12-02       Impact factor: 6.543

10.  Melatonin Protects Against Ischemic Brain Injury by Modulating PI3K/AKT Signaling Pathway via Suppression of PTEN Activity.

Authors:  Yuanyuan Ran; Lin Ye; Zitong Ding; Fuhai Gao; Shuiqing Yang; Boyan Fang; Zongjian Liu; Jianing Xi
Journal:  ASN Neuro       Date:  2021 Jan-Dec       Impact factor: 4.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.